Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases

•Leptin is not only participates in the occurrence of liver fibrosis, but also has important significance in relieving liver fibrosis.•Leptin promotes lung, heart, and kidney fibrosis;•Leptin regulates adipose tissue fibrosis. Leptin is a small peptide mainly secreted by adipocyte, which acts on the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2022-05, Vol.106, p.108608-108608, Article 108608
Hauptverfasser: Liu, Yuexia, Li, Yizhou, Liang, Juntong, Sun, Zhuwen, Wu, Qiong, Liu, Yongnian, Sun, Chao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 108608
container_issue
container_start_page 108608
container_title International immunopharmacology
container_volume 106
creator Liu, Yuexia
Li, Yizhou
Liang, Juntong
Sun, Zhuwen
Wu, Qiong
Liu, Yongnian
Sun, Chao
description •Leptin is not only participates in the occurrence of liver fibrosis, but also has important significance in relieving liver fibrosis.•Leptin promotes lung, heart, and kidney fibrosis;•Leptin regulates adipose tissue fibrosis. Leptin is a small peptide mainly secreted by adipocyte, which acts on the central nervous system of the hypothalamus to regulate the body's energy balance by inhibiting food intake, it also can directly act on specific cells through leptin receptors (for example, ObRa, which exists in the blood–brain barrier or kidneys), thereby affect cell metabolism. Excessive deposition of extracellular matrix (ECM) causes damage to normal tissues or destruction of organ structure, which will eventually lead to tissue or organ fibrosis. The sustainable development of fibrosis can lead to structural damage and functional decline of organs, and even exhaustion, which seriously threatens human health and life. In recent years, studies have found that leptin directly alleviates the fibrosis process of various tissues and organs in mammals. Therefore, we speculate that leptin may become a significant treatment for fibrosis of various tissues and organs in the future. So, the main purpose of this review is to explore the specific mechanism of leptin in the process of fibrosis in multiple tissues and organs, and to provide a theoretical basis for the treatment of various tissues and organs fibrosis and related diseases caused by it, which is of great significance in the future.
doi_str_mv 10.1016/j.intimp.2022.108608
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2630921590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576922000923</els_id><sourcerecordid>2658289183</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-b723812e99d6661cff7a57358c712f85a208019cf3693bc2bb7914800a14e4233</originalsourceid><addsrcrecordid>eNp9kEtrFTEYhoMo9uY_EAm46WaOuUxuLoRSbCsccKOrLkIm84XmMDeTTKH_vjlMdeGiq4Qvz_smeRD6SMmOEiq_HHZxKnFcdowwVkdaEv0GnVKtdEMVEW_rXkjVCCXNCTrL-UBInbf0PTrhgmoimTxF93tYSpy-YjdhmEp6wstce3GYEy4PgEsCV8Z6gueAF0hxeYDkBlxizivgELs055hrvMcJBlegx33M4DLkC_QuuCHDh5f1HP2--f7r-q7Z_7z9cX21bzw3pDSdYlxTBsb0UkrqQ1BOKC60V5QFLRwjmlDjA5eGd551nTK01YQ42kLLOD9Hl1vvkuY_K-Rix5g9DIObYF6zZZITw6gwpKKf_0MP85qm-rpKCc20ofpY2G6Ur5_LCYJdUhxderKU2KN8e7CbfHuUbzf5NfbppXztRuj_hf7arsC3DYBq4zFCstlHmDz0MYEvtp_j6zc8A80nlg0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2658289183</pqid></control><display><type>article</type><title>Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Liu, Yuexia ; Li, Yizhou ; Liang, Juntong ; Sun, Zhuwen ; Wu, Qiong ; Liu, Yongnian ; Sun, Chao</creator><creatorcontrib>Liu, Yuexia ; Li, Yizhou ; Liang, Juntong ; Sun, Zhuwen ; Wu, Qiong ; Liu, Yongnian ; Sun, Chao</creatorcontrib><description>•Leptin is not only participates in the occurrence of liver fibrosis, but also has important significance in relieving liver fibrosis.•Leptin promotes lung, heart, and kidney fibrosis;•Leptin regulates adipose tissue fibrosis. Leptin is a small peptide mainly secreted by adipocyte, which acts on the central nervous system of the hypothalamus to regulate the body's energy balance by inhibiting food intake, it also can directly act on specific cells through leptin receptors (for example, ObRa, which exists in the blood–brain barrier or kidneys), thereby affect cell metabolism. Excessive deposition of extracellular matrix (ECM) causes damage to normal tissues or destruction of organ structure, which will eventually lead to tissue or organ fibrosis. The sustainable development of fibrosis can lead to structural damage and functional decline of organs, and even exhaustion, which seriously threatens human health and life. In recent years, studies have found that leptin directly alleviates the fibrosis process of various tissues and organs in mammals. Therefore, we speculate that leptin may become a significant treatment for fibrosis of various tissues and organs in the future. So, the main purpose of this review is to explore the specific mechanism of leptin in the process of fibrosis in multiple tissues and organs, and to provide a theoretical basis for the treatment of various tissues and organs fibrosis and related diseases caused by it, which is of great significance in the future.</description><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2022.108608</identifier><identifier>PMID: 35180626</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Blood-brain barrier ; Central nervous system ; Energy balance ; Extracellular matrix ; Fibrosis ; Food intake ; Health risks ; Hypothalamus ; Leptin ; Leptin receptors ; Metabolism ; Organs ; Structural damage ; Structure-function relationships ; Sustainable development ; Tissues</subject><ispartof>International immunopharmacology, 2022-05, Vol.106, p.108608-108608, Article 108608</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV May 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-b723812e99d6661cff7a57358c712f85a208019cf3693bc2bb7914800a14e4233</citedby><cites>FETCH-LOGICAL-c390t-b723812e99d6661cff7a57358c712f85a208019cf3693bc2bb7914800a14e4233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intimp.2022.108608$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35180626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yuexia</creatorcontrib><creatorcontrib>Li, Yizhou</creatorcontrib><creatorcontrib>Liang, Juntong</creatorcontrib><creatorcontrib>Sun, Zhuwen</creatorcontrib><creatorcontrib>Wu, Qiong</creatorcontrib><creatorcontrib>Liu, Yongnian</creatorcontrib><creatorcontrib>Sun, Chao</creatorcontrib><title>Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>•Leptin is not only participates in the occurrence of liver fibrosis, but also has important significance in relieving liver fibrosis.•Leptin promotes lung, heart, and kidney fibrosis;•Leptin regulates adipose tissue fibrosis. Leptin is a small peptide mainly secreted by adipocyte, which acts on the central nervous system of the hypothalamus to regulate the body's energy balance by inhibiting food intake, it also can directly act on specific cells through leptin receptors (for example, ObRa, which exists in the blood–brain barrier or kidneys), thereby affect cell metabolism. Excessive deposition of extracellular matrix (ECM) causes damage to normal tissues or destruction of organ structure, which will eventually lead to tissue or organ fibrosis. The sustainable development of fibrosis can lead to structural damage and functional decline of organs, and even exhaustion, which seriously threatens human health and life. In recent years, studies have found that leptin directly alleviates the fibrosis process of various tissues and organs in mammals. Therefore, we speculate that leptin may become a significant treatment for fibrosis of various tissues and organs in the future. So, the main purpose of this review is to explore the specific mechanism of leptin in the process of fibrosis in multiple tissues and organs, and to provide a theoretical basis for the treatment of various tissues and organs fibrosis and related diseases caused by it, which is of great significance in the future.</description><subject>Blood-brain barrier</subject><subject>Central nervous system</subject><subject>Energy balance</subject><subject>Extracellular matrix</subject><subject>Fibrosis</subject><subject>Food intake</subject><subject>Health risks</subject><subject>Hypothalamus</subject><subject>Leptin</subject><subject>Leptin receptors</subject><subject>Metabolism</subject><subject>Organs</subject><subject>Structural damage</subject><subject>Structure-function relationships</subject><subject>Sustainable development</subject><subject>Tissues</subject><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtrFTEYhoMo9uY_EAm46WaOuUxuLoRSbCsccKOrLkIm84XmMDeTTKH_vjlMdeGiq4Qvz_smeRD6SMmOEiq_HHZxKnFcdowwVkdaEv0GnVKtdEMVEW_rXkjVCCXNCTrL-UBInbf0PTrhgmoimTxF93tYSpy-YjdhmEp6wstce3GYEy4PgEsCV8Z6gueAF0hxeYDkBlxizivgELs055hrvMcJBlegx33M4DLkC_QuuCHDh5f1HP2--f7r-q7Z_7z9cX21bzw3pDSdYlxTBsb0UkrqQ1BOKC60V5QFLRwjmlDjA5eGd551nTK01YQ42kLLOD9Hl1vvkuY_K-Rix5g9DIObYF6zZZITw6gwpKKf_0MP85qm-rpKCc20ofpY2G6Ur5_LCYJdUhxderKU2KN8e7CbfHuUbzf5NfbppXztRuj_hf7arsC3DYBq4zFCstlHmDz0MYEvtp_j6zc8A80nlg0</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Liu, Yuexia</creator><creator>Li, Yizhou</creator><creator>Liang, Juntong</creator><creator>Sun, Zhuwen</creator><creator>Wu, Qiong</creator><creator>Liu, Yongnian</creator><creator>Sun, Chao</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20220501</creationdate><title>Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases</title><author>Liu, Yuexia ; Li, Yizhou ; Liang, Juntong ; Sun, Zhuwen ; Wu, Qiong ; Liu, Yongnian ; Sun, Chao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-b723812e99d6661cff7a57358c712f85a208019cf3693bc2bb7914800a14e4233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood-brain barrier</topic><topic>Central nervous system</topic><topic>Energy balance</topic><topic>Extracellular matrix</topic><topic>Fibrosis</topic><topic>Food intake</topic><topic>Health risks</topic><topic>Hypothalamus</topic><topic>Leptin</topic><topic>Leptin receptors</topic><topic>Metabolism</topic><topic>Organs</topic><topic>Structural damage</topic><topic>Structure-function relationships</topic><topic>Sustainable development</topic><topic>Tissues</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yuexia</creatorcontrib><creatorcontrib>Li, Yizhou</creatorcontrib><creatorcontrib>Liang, Juntong</creatorcontrib><creatorcontrib>Sun, Zhuwen</creatorcontrib><creatorcontrib>Wu, Qiong</creatorcontrib><creatorcontrib>Liu, Yongnian</creatorcontrib><creatorcontrib>Sun, Chao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yuexia</au><au>Li, Yizhou</au><au>Liang, Juntong</au><au>Sun, Zhuwen</au><au>Wu, Qiong</au><au>Liu, Yongnian</au><au>Sun, Chao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>106</volume><spage>108608</spage><epage>108608</epage><pages>108608-108608</pages><artnum>108608</artnum><issn>1567-5769</issn><eissn>1878-1705</eissn><abstract>•Leptin is not only participates in the occurrence of liver fibrosis, but also has important significance in relieving liver fibrosis.•Leptin promotes lung, heart, and kidney fibrosis;•Leptin regulates adipose tissue fibrosis. Leptin is a small peptide mainly secreted by adipocyte, which acts on the central nervous system of the hypothalamus to regulate the body's energy balance by inhibiting food intake, it also can directly act on specific cells through leptin receptors (for example, ObRa, which exists in the blood–brain barrier or kidneys), thereby affect cell metabolism. Excessive deposition of extracellular matrix (ECM) causes damage to normal tissues or destruction of organ structure, which will eventually lead to tissue or organ fibrosis. The sustainable development of fibrosis can lead to structural damage and functional decline of organs, and even exhaustion, which seriously threatens human health and life. In recent years, studies have found that leptin directly alleviates the fibrosis process of various tissues and organs in mammals. Therefore, we speculate that leptin may become a significant treatment for fibrosis of various tissues and organs in the future. So, the main purpose of this review is to explore the specific mechanism of leptin in the process of fibrosis in multiple tissues and organs, and to provide a theoretical basis for the treatment of various tissues and organs fibrosis and related diseases caused by it, which is of great significance in the future.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35180626</pmid><doi>10.1016/j.intimp.2022.108608</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1567-5769
ispartof International immunopharmacology, 2022-05, Vol.106, p.108608-108608, Article 108608
issn 1567-5769
1878-1705
language eng
recordid cdi_proquest_miscellaneous_2630921590
source Elsevier ScienceDirect Journals Complete
subjects Blood-brain barrier
Central nervous system
Energy balance
Extracellular matrix
Fibrosis
Food intake
Health risks
Hypothalamus
Leptin
Leptin receptors
Metabolism
Organs
Structural damage
Structure-function relationships
Sustainable development
Tissues
title Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A56%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leptin:%20an%20entry%20point%20for%20the%20treatment%20of%20peripheral%20tissue%20fibrosis%20and%20related%20diseases&rft.jtitle=International%20immunopharmacology&rft.au=Liu,%20Yuexia&rft.date=2022-05-01&rft.volume=106&rft.spage=108608&rft.epage=108608&rft.pages=108608-108608&rft.artnum=108608&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2022.108608&rft_dat=%3Cproquest_cross%3E2658289183%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2658289183&rft_id=info:pmid/35180626&rft_els_id=S1567576922000923&rfr_iscdi=true